Scientific Online Resource System

Varna Medical Forum

Refractory epilepsy - New treatment technologies. chance and future for the children

Dimitrina Blagoeva, Stella Grozeva, Nadka Vasileva, Desislava Todorova

Abstract

Epilepsy is an umbrella clinical term which encompasses various chronic conditions of the cerebrum, characterized by recurring seizures resulting from overstimulation of certain groups of neurons. Clinically, these disorders manifest in various transitory sensory, motor, autonomous, behavioural or mental symptoms. The word epilepsy comes from the Greek word `επιληψία` , meaning `to seize`, `to assault`, `to attack`. The disease is also known as morbus sacer (Latin for sacred disease). It has been known to humanity for thousands of years. The first symptoms can manifest in any age, with two age groups being most vulnerable - children and people over 70. More than 50% of the cases of epilepsy start before the age of 10 and 75% before the age of 20. Based on the cause, epilepsy is divided into two main groups - symptomatic epilepsy which starts in adult age and idiopathic (with unknown cause) epilepsy that is more common in adolescence. The diagnostic process in the case of people suffering from epilepsy involves several successive stages: characterizing and establishing the type of epileptic seizure; classifying the epilepsy syndrome; clarifying the etiology of the disease. The main treatment methods involve anti-epileptic drugs, surgery and ketogenic diet and these methods often complement each other. But in some patients, the disease is not affected by the drugs, this is the so-called refractory epilepsy. The most common complication in patients with severe refractory epilepsy is the cognitive deficit which sets in gradually as a result of the recurring epileptic seizures which can become as many as 100 per day. Today, with the development of medical science, surgical treatment of refractory epilepsy is now changing thanks to the new medical technologies. The big medical and social importance of refractory epilepsy is due not only to the wide spread of the disease but also because it affects mostly children and adolescents.

Full Text


References

Делев D; Изпрати K; Malter M; Ormond DR; Parpaley Y; Фон Lehe M; Шрам J; Grote А. Световната неврохирургия. 84 (6): 171925.e1 2015 декември [оценяване проучвания. Вестник член. Research Support, Nonно която осъществява. Gov’t]

Е. Viteva, Z. Zahariev. Епилепсия и резистентност. 2006, Bulg. Nevrol. 6.

L. Chakova. Съвременни аспекти на детската епилепсия – част, лечение и прогноза. 1998, Neurologia Balcanica, 2, 1998

Минкин, К., Димова, Д., Габровски, К., Найденов, Е., Пенков, М., Божинова, В., Романски, К., Бусарски, В., Маринов, М Колозотомия при пациенти с генерализирана фармакорезистентна епилепсия // Българска неврология, февруари, 2013.

Минкин, К., Димова, Д., Начев, С., Найденов, Е., Габровски, К., Такова, Р., Пенков, М., Божинова, В., Маринов, М., Романски, К., Бусарски, В. Съвременна хирургия за медикаментозно резистентна епилепсия в България // Българска неврология, февруари, 2013.

Андреева-Гатева, П., С. Георгиева, Е. Харитов, Н. Бояджиева. Наука и младост. Сборник научни съобщения от конкурсна сесия 2013 г., Пловдив, 2013.

Guerrini R. Epilepsy in children. Lancet 2006; 367: 499

Масларов, Д. Неврология – за факултетите по обществено здраве. София, Темпора ЕООД, 2010.

Цеков, Ст. Епилепсия, същност, диагностични възможности и терапевтични принципи. В., изд. Зограф, 2003.

Под редакцията на Шотеков, П. Неврология. Медицинско издателство, Арсо.

Шотеков, П. Неврология. С., Мед. изд. Арсо, 2010.




DOI: http://dx.doi.org/10.14748/vmf.v5i0.2813

Refbacks

Font Size


|